Literature DB >> 21383007

Bit-1 mediates integrin-dependent cell survival through activation of the NFkappaB pathway.

Genevieve S Griffiths1, Melanie Grundl, Anna Leychenko, Silke Reiter, Shirley S Young-Robbins, Florian J Sulzmaier, Maisel J Caliva, Joe W Ramos, Michelle L Matter.   

Abstract

Loss of properly regulated cell death and cell survival pathways can contribute to the development of cancer and cancer metastasis. Cell survival signals are modulated by many different receptors, including integrins. Bit-1 is an effector of anoikis (cell death due to loss of attachment) in suspended cells. The anoikis function of Bit-1 can be counteracted by integrin-mediated cell attachment. Here, we explored integrin regulation of Bit-1 in adherent cells. We show that knockdown of endogenous Bit-1 in adherent cells decreased cell survival and re-expression of Bit-1 abrogated this effect. Furthermore, reduction of Bit-1 promoted both staurosporine and serum-deprivation induced apoptosis. Indeed knockdown of Bit-1 in these cells led to increased apoptosis as determined by caspase-3 activation and positive TUNEL staining. Bit-1 expression protected cells from apoptosis by increasing phospho-IκB levels and subsequently bcl-2 gene transcription. Protection from apoptosis under serum-free conditions correlated with bcl-2 transcription and Bcl-2 protein expression. Finally, Bit-1-mediated regulation of bcl-2 was dependent on focal adhesion kinase, PI3K, and AKT. Thus, we have elucidated an integrin-controlled pathway in which Bit-1 is, in part, responsible for the survival effects of cell-ECM interactions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21383007      PMCID: PMC3077668          DOI: 10.1074/jbc.M111.228387

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

Review 1.  Mechanisms of focal adhesion kinase regulation.

Authors:  Lee Ann Cohen; Jun-Lin Guan
Journal:  Curr Cancer Drug Targets       Date:  2005-12       Impact factor: 3.428

Review 2.  Regulation of angiogenesis: apoptotic cues from the ECM.

Authors:  D A Cheresh; D G Stupack
Journal:  Oncogene       Date:  2008-10-20       Impact factor: 9.867

3.  Vascular endothelial growth factor signalling in endothelial cell survival: a role for NFkappaB.

Authors:  Jennifer Grosjean; Serafim Kiriakidis; Kerri Reilly; Marc Feldmann; Ewa Paleolog
Journal:  Biochem Biophys Res Commun       Date:  2005-12-27       Impact factor: 3.575

4.  TGF-beta coordinately activates TAK1/MEK/AKT/NFkB and SMAD pathways to promote osteoclast survival.

Authors:  Anne Gingery; Elizabeth W Bradley; Larry Pederson; Ming Ruan; Nikki J Horwood; Merry Jo Oursler
Journal:  Exp Cell Res       Date:  2008-06-13       Impact factor: 3.905

5.  Signaling and regulatory mechanisms of integrin alphavbeta6 on the apoptosis of colon cancer cells.

Authors:  Zhang Zhao-Yang; Xu Ke-Sen; He Qing-Si; Niu Wei-Bo; Wang Jia-Yong; Mi Yue-Tang; Wang Jin-Shen; Wang Guo-Qiang; Yang Guang-Yun; Niu Jun
Journal:  Cancer Lett       Date:  2008-04-01       Impact factor: 8.679

6.  Focal adhesion kinase mediates cell survival via NF-kappaB and ERK signaling pathways.

Authors:  Danshan Huang; Michelle Khoe; Merone Befekadu; Sue Chung; Yasunori Takata; Dusko Ilic; Michael Bryer-Ash
Journal:  Am J Physiol Cell Physiol       Date:  2006-11-29       Impact factor: 4.249

Review 7.  The RSK family of kinases: emerging roles in cellular signalling.

Authors:  Rana Anjum; John Blenis
Journal:  Nat Rev Mol Cell Biol       Date:  2008-10       Impact factor: 94.444

8.  Protein kinase D is a positive regulator of Bit1 apoptotic function.

Authors:  Hector Biliran; Yiwen Jan; Renwei Chen; Elena B Pasquale; Erkki Ruoslahti
Journal:  J Biol Chem       Date:  2008-08-14       Impact factor: 5.157

Review 9.  Anoikis resistance and tumor metastasis.

Authors:  Craig D Simpson; Kika Anyiwe; Aaron D Schimmer
Journal:  Cancer Lett       Date:  2008-06-24       Impact factor: 8.679

10.  Anoikis effector Bit1 negatively regulates Erk activity.

Authors:  Rania Kairouz-Wahbe; Hector Biliran; Xiuquan Luo; Ingwei Khor; Miriam Wankell; Cynthia Besch-Williford; Jaime Pascual; Robert Oshima; Erkki Ruoslahti
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-24       Impact factor: 11.205

View more
  23 in total

Review 1.  A review of the association between osteosarcoma metastasis and protein translation.

Authors:  T S Osborne; C Khanna
Journal:  J Comp Pathol       Date:  2012-01-31       Impact factor: 1.311

2.  Bit1-a novel regulator of astrocyte function during retinal development: proliferation, migration, and paracrine effects on vascular endothelial cell.

Authors:  Yan Liu; Jiali Ji; Wanyu Shao; Min Luo; Bo Ma
Journal:  Hum Cell       Date:  2019-07-31       Impact factor: 4.174

3.  Downregulation of Bit1 expression promotes growth, anoikis resistance, and transformation of immortalized human bronchial epithelial cells via Erk activation-dependent suppression of E-cadherin.

Authors:  Xin Yao; Selena Gray; Tri Pham; Mychael Delgardo; An Nguyen; Stephen Do; Shubha Kale Ireland; Renwei Chen; Asim B Abdel-Mageed; Hector Biliran
Journal:  Biochem Biophys Res Commun       Date:  2017-11-21       Impact factor: 3.575

4.  Bit1-a potential positive regulator of epithelial-mesenchymal transition in lens epithelial cells.

Authors:  Xinhua Wu; Jing Ruan; Bo Ma; Min Luo
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-04-28       Impact factor: 3.117

5.  Implications of Bit1 and AIF overexpressions in esophageal squamous cell carcinoma.

Authors:  Tianli Fan; Fang Tian; Shanyong Yi; Yang Ke; Shengna Han; Lirong Zhang; Hongtao Liu
Journal:  Tumour Biol       Date:  2013-08-17

6.  PTRH2 gene mutation causes progressive congenital skeletal muscle pathology.

Authors:  Jinger Doe; Angela M Kaindl; Mayumi Jijiwa; Michelle de la Vega; Hao Hu; Genevieve S Griffiths; Tatiana M Fontelonga; Pamela Barraza; Vivian Cruz; Pam Van Ry; Joe W Ramos; Dean J Burkin; Michelle L Matter
Journal:  Hum Mol Genet       Date:  2017-04-15       Impact factor: 6.150

7.  Bit-1 is an essential regulator of myogenic differentiation.

Authors:  Genevieve S Griffiths; Jinger Doe; Mayumi Jijiwa; Pam Van Ry; Vivian Cruz; Michelle de la Vega; Joe W Ramos; Dean J Burkin; Michelle L Matter
Journal:  J Cell Sci       Date:  2015-03-13       Impact factor: 5.285

8.  Genomic and transcriptomic characterisation of undifferentiated pleomorphic sarcoma of bone.

Authors:  Naser M Ali; Stefania Niada; Anna T Brini; Mark R Morris; Sathishkumar Kurusamy; Abdullah Alholle; David Huen; Cristina R Antonescu; Franck Tirode; Vaiyapuri Sumathi; Farida Latif
Journal:  J Pathol       Date:  2018-12-27       Impact factor: 7.996

Review 9.  Bit1 in anoikis resistance and tumor metastasis.

Authors:  Scott Jenning; Tri Pham; Shubha Kale Ireland; Erkki Ruoslahti; Hector Biliran
Journal:  Cancer Lett       Date:  2013-01-31       Impact factor: 8.679

10.  Biallelic MADD variants cause a phenotypic spectrum ranging from developmental delay to a multisystem disorder.

Authors:  Pauline E Schneeberger; Fanny Kortüm; Georg Christoph Korenke; Malik Alawi; René Santer; Mathias Woidy; Daniela Buhas; Stephanie Fox; Jane Juusola; Majid Alfadhel; Bryn D Webb; Emanuele G Coci; Rami Abou Jamra; Manuela Siekmeyer; Saskia Biskup; Corina Heller; Esther M Maier; Poupak Javaher-Haghighi; Maria F Bedeschi; Paola F Ajmone; Maria Iascone; Hilde Peeters; Katleen Ballon; Jaak Jaeken; Aroa Rodríguez Alonso; María Palomares-Bralo; Fernando Santos-Simarro; Marije E C Meuwissen; Diane Beysen; R Frank Kooy; Henry Houlden; David Murphy; Mohammad Doosti; Ehsan G Karimiani; Majid Mojarrad; Reza Maroofian; Lenka Noskova; Stanislav Kmoch; Tomas Honzik; Heidi Cope; Amarilis Sanchez-Valle; Bruce D Gelb; Ingo Kurth; Maja Hempel; Kerstin Kutsche
Journal:  Brain       Date:  2020-08-01       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.